| 产品详情 |
| Edit |   |
|---|
| Product Name | BD3, Recombinant, Human (beta Defensin-3) |
|---|
| Description | Purity ≥ 95%, as determined by SDS-PAGE under reducing conditions and visualized by silver stain. Endotoxin ≤ 1EU. Beta-Defensin 3, also known as BD3 and DEFB-3, is a membrane-active cationic peptide that functions in inflammation and innate immune responses. There are at least 30 beta-Defensins which are distinguished from alpha-Defensins by the connectivity pattern of their three intramolecular disulfide bonds (1). The 45 aa mature human BD3 shares 38% and 33% aa sequence identity with mouse and rat BD3, respectively (2, 3). It shares 18%-36% aa sequence identity with other human beta-Defensins. BD3 is widely expressed among epithelial tissues, notably by keratinocytes and airway epithelial cells. It is upregulated in response to proinflammatory cytokines, microbial and viral infections, and at the edges of skin wounds (2, 4-6). BD3 induction in osteoarthritis chondrocytes promotes MMP1 and 13 production and inhibits TIMP1 and 2 expression (7). In vivo control of BD3 activity is acco |
|---|
| Size | 50ug |
|---|
| Concentration | n/a |
|---|
| Applications | FC WB |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | Accession: NP_061131, SwissProt: P81534 |
|---|
| Catalog # | B0902-01C |
|---|
| Price | |
|---|
| Order / More Info | BD3, Recombinant, Human (beta Defensin-3) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|